Oppenheimer lifted its price target on Sarepta Therapeutics (Nasdaq: SRPT) from $45 to $60 sending the stock price soaring $3.77 to close at $23.30.
Sarepta Therapeutics price target lifted
April 06, 2016 at 17:28 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.